Entianin, a novel subtilin-like lantibiotic from Bacillus subtilis subsp. spizizenii DSM 15029T with high antimicrobial activity

Applied and Environmental Microbiology

Volumn 77, Issue 5, 2011, Pages 1698-1707

  Fuchs, Sebastian W ^a   Jaskolla, Thorsten W ^a   Bochmann, Sophie ^a   Kötter, Peter ^a   Wichelhaus, Thomas ^b   Karas, Michael ^a   Stein, Torsten ^a,c   Entian, Karl Dieter ^a  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^c AALEN UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID SEQUENCE; ANTI-MICROBIAL ACTIVITY; ANTIBIOTIC ACTIVITY; AUTOINDUCTION; BACILLUS SUBTILIS; DNA SEQUENCING; ENTEROCOCCUS FAECALIS; GRAM-POSITIVE PATHOGENS; LANTHIONINES; LANTIBIOTICS; MASS SPECTROMETRIC ANALYSIS; MOLECULAR MECHANISM; POST-TRANSLATIONAL MODIFICATIONS; PRIMARY STRUCTURES; RANEY NICKEL; REDUCTIVE CLEAVAGE; REPORTER SYSTEMS; STAPHYLOCOCCUS AUREUS; STRUCTURAL GENE; SUBTILIN; SUBTILIS; TANDEM MASS SPECTROMETRY;

AMINO ACIDS; BACILLI; BACTERIOLOGY; BIOASSAY; GENE ENCODING; MASS SPECTROMETRY; MICROORGANISMS;

ANTIBIOTICS;

BACTERIAL DNA; BACTERIOCIN;

AMINO ACID; ANTIBIOTICS; ANTIMICROBIAL ACTIVITY; BACTERIUM; BIOASSAY; BIOCONTROL AGENT; CATALYSIS; GROWTH RATE; INHIBITION; MASS SPECTROMETRY; MOLECULAR ANALYSIS; NICKEL;

AMINO ACID SEQUENCE; ARTICLE; BACILLUS SUBTILIS; BACTERIAL GENE; BIOSYNTHESIS; CHEMISTRY; DNA SEQUENCE; DRUG EFFECT; ENTEROCOCCUS FAECALIS; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MOLECULAR GENETICS; MULTIGENE FAMILY; NUCLEOTIDE SEQUENCE; STAPHYLOCOCCUS AUREUS; TANDEM MASS SPECTROMETRY;

AMINO ACID SEQUENCE; BACILLUS SUBTILIS; BACTERIOCINS; BIOSYNTHETIC PATHWAYS; DNA, BACTERIAL; ENTEROCOCCUS FAECALIS; GENES, BACTERIAL; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MULTIGENE FAMILY; SEQUENCE ANALYSIS, DNA; STAPHYLOCOCCUS AUREUS; TANDEM MASS SPECTROMETRY;

BACILLUS SUBTILIS SUBSP. SPIZIZENII; ENTEROCOCCUS FAECALIS; POSIBACTERIA; STAPHYLOCOCCUS AUREUS;

EID: 79953188729     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.01962-10     Document Type: Article

References (45)

1. Bierbaum, G., and H. G. Sahl. 2009. Lantibiotics: mode of action, biosynthesis and bioengineering. Curr. Pharm. Biotechnol. 10:2-18.
2. Breukink, E., and B. de Kruijff. 1999. The lantibiotic nisin, a special case or not? Biochim. Biophys. Acta 1462:223-234.
3. Breukink, E., et al. 1999. Use of the cell wall precursor lipid II by a poreforming peptide antibiotic. Science 286:2361-2364.
4. Brötz, H., et al. 1998. Role of lipid-bound peptidoglycan precursors in the formation of pores by nisin, epidermin and other lantibiotics. Mol. Microbiol. 30:317-327.
5. Brumfitt, W., M. R. Salton, and J. M. Hamilton-Miller. 2002. Nisin, alone and combined with peptidoglycan-modulating antibiotics: activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci. J. Antimicrob. Chemother. 50:731-734.
6. Burkard, M., K. D. Entian, and T. Stein. 2007. Development and application of a microtiter plate-based autoinduction bioassay for detection of the lantibiotic subtilin. J. Microbiol. Methods 70:179-185.
7. Burkard, M., and T. Stein. 2008. Microtiter plate bioassay to monitor the interference of antibiotics with the lipid II cycle essential for peptidoglycan biosynthesis. J. Microbiol. Methods 75:70-74.
8. Chan, C. W., B. W. Bycroft, M. L. Leyland, L.-Y. Lian, and G. C. Roberts. 1993. A novel posttranslational modification of the peptide antibiotic subtilin: isolation and characterization of a natural variant from Bacillus subtilis ATCC 6633. Biochem. J. 291:23-27.
9. Chatterjee, C., M. Paul, L. Xie, and W. A. van der Donk. 2005. Biosynthesis and mode of action of lantibiotics. Chem. Rev. 105:633-684.
10. Georgalaki, M. D., et al. 2002. Macedocin, a food-grade lantibiotic produced by Streptococcus macedonicus ACA-DC 198. Appl. Environ. Microbiol. 68: 5891-5903.
11. Giacometti, A., O. Cirioni, F. Barchiesi, and G. Scalise. 2000. In-vitro activity and killing effect of polycationic peptides on methicillin-resistant Staphylococcus aureus and interactions with clinically used antibiotics. Diagn. Microbiol. Infect. Dis. 38:115-118.
12. Gross, E. 1975. Subtilin and nisin: the chemistry and biology of peptides with alpha, beta-unsaturated amino acids, p. 31-42. In R. Walter and J. Meienhofer (ed.), Peptides: chemistry, structure, and biology: proceedings of the fourth American Peptide Symposium. Ann Arbor Science, Ann Arbor, MI.
13. Gross, E. 1978. Polypeptide antibiotics, p. 415-462. In M. J. Weinstein and G. H. Wagman (ed.), Antibiotics: isolation, separation and purification. Elsevier, New York, NY.
14. Gross, E., H. H. Kiltz, and E. Nebelin. 1973. Subtilin, VI: the structure of subtilin. Hoppe-Seylers Z. Physiol. Chem. 354:810-812. (In German.)
15. Halami, P. M., T. Stein, A. Chandrashekar, and K.-D. Entian. 2010. Maturation and processing of SpaI, the lipoprotein involved in subtilin immunity in Bacillus subtilis ATCC 6633. Microbiol. Res. 165:183-189.
16. Hansen, J. N. 1994. Nisin as a model food preservative. Crit. Rev. Food Sci. Nutr. 34:69-93.
17. Harris, J. L., et al. 2000. Rapid and general profiling of protease specificity by using combinatorial fluorogenic substrate libraries. Proc. Natl. Acad. Sci. U. S. A. 97:7754-7759.
18. Hasper, H. E., B. de Kruijff, and E. Breukink. 2004. Assembly and stability of nisin-lipid II pores. Biochemistry 43:11567-11575.
19. Hasper, H. E., et al. 2006. An alternative bactericidal mechanism of action for lantibiotic peptides that target lipid II. Science 313:1636-1637.
20. Heinzmann, S., K. D. Entian, and T. Stein. 2006. Engineering Bacillus subtilis ATCC 6633 for improved production of the lantibiotic subtilin. Appl. Microbiol. Biotechnol. 69:532-536.
21. Hsu, S. T., et al. 2004. The nisin-lipid II complex reveals a pyrophosphate cage that provides a blueprint for novel antibiotics. Nat. Struct. Mol. Biol. 11:963-967.
22. Jaskolla, T. W., W.-D. Lehmann, and M. Karas. 2008. 4-Chloro-α-cyanocinnamic acid is an advanced, rationally designed MALDI matrix. Proc. Natl. Acad. Sci. U. S. A. 105:12200-12205.
23. Jaskolla, T. W., D. G. Papasotiriou, and M. Karas. 2009. Comparison between the matrices alpha-cyano-4-hydroxycinnamic acid and 4-chloro-alphacyanocinnamic acid for trypsin, chymotrypsin, and pepsin digestions by MALDI-TOF mass spectrometry. J. Proteome Res. 8:3588-3597.
24. Kawulka, K. E., et al. 2004. Structure of subtilosin A, a cyclic antimicrobial peptide from Bacillus subtilis with unusual sulfur to α-carbon cross-links: formation and reduction of α-thio-α-amino acid derivatives. Biochemistry 43:3385-3395.
25. Kiesau, P., et al. 1997. Evidence for a multimeric subtilin synthetase complex. J. Bacteriol. 179:1475-1481.
26. Klein, C., C. Kaletta, N. Schnell, and K. D. Entian. 1992. Analysis of genes involved in biosynthesis of the lantibiotic subtilin. Appl. Environ. Microbiol. 58:132-142.
27. Klein, C. C. Kaletta, and K. D. Entian. 1993. Biosynthesis of the lantibiotic Subtilin is regulated by a histidin kinase/response regulator system. Appl. Environ. Microbiol. 59:296-303.
28. Klein, C., and K. D. Entian. 1994. Genes involved in self-protection against the lantibiotic subtilin produced by Bacillus subtilis ATCC 6633. Appl. Environ. Microbiol. 60:2793-2801.
29. Kuipers, O. P., M. M. Beerthuyzen, P. G. de Ruyter, E. J. Luesink, and W. M. de Vos. 1995. Autoregulation of nisin biosynthesis in Lactococcus lactis by signal transduction. J. Biol. Chem. 270:27299-27304.
30. Landy, M., G. H. Warren, S. B. Rosenman, and L. G. Colio. 1948. Bacillomycin: an antibiotic from Bacillus subtilis active against pathogenic fungi. Proc. Soc. Exp. Biol. Med. 67:539-541.
31. Mascher, T., S. L. Zimmer, T. A. Smith, and J. D. Helmann. 2004. Antibiotic-inducible promoter regulated by the cell envelope stress-sensing twocomponent system LiaRS of Bacillus subtilis. Antimicrob. Agents Chemother. 48:2888-2896.
32. Mota-Meira, M., G. Lapointe, C. Lacroix, and M. C. Lavoie. 2000. MICs of mutacin B-Ny266, nisin A, vancomycin, and oxacillin against bacterial pathogens. Antimicrob. Agents Chemother. 44:24-29.
33. Müller, W. M., T. Schmiederer, P. Ensle, and R. D. Süssmuth. 2010. In vitro biosynthesis of the prepeptide of type-III lantibiotic labyrinthopeptin A2 including formation of a C-C bond as a post-translational modification. Angew. Chem. Int. Ed. Engl. 49:2436-2440.
34. Nakamura, L. K., M. S. Roberts, and F. M. Cohan. 1999. Relationship of Bacillus subtilis clades associated with strains 168 and W23: a proposal for Bacillus subtilis subsp. subtilis subsp. nov. and Bacillus subtilis subsp. spizizenii subsp. nov. Int. J. Syst. Bacteriol. 49:1211-1215.
35. Normenausschuss Medizin im DIN, Deutsches Institut für Normung e.V. 1999. Microdilution methods. DIN 58940-8. Deutsches Institut für Normung e.V., Berlin, Germany.
36. Olson, B. J., and J. Markwell. 2007. Assays for determination of protein concentration. Curr. Protoc. Protein Sci. Chapter 3, Unit 3.4.
37. Petricci, E., M. Renzulli, M. Radi, F. Corelli, and M. Botta. 2002. Solidphase synthesis (SPS) of substituted uracils via Oxone cleavage methodology. Tetrahedron Lett. 43:9667-9670.
38. Piper, C., L. A. Draper, P. D. Cotter, R. P. Ross, and C. Hill. 2009. A comparison of the activities of lacticin 3147 and nisin against drug-resistant Staphylococcus aureus and Enterococcus species. J. Antimicrob. Chemother. 64:546-551.
39. Schnell, N., et al. 1988. Prepeptide sequence of epidermin, a ribosomally synthesized antibiotic with four sulphide-rings. Nature 333:276-278.
40. Schnell, N., et al. 1989. Structural gene isolation and prepeptide sequence of gallidermin, a new lanthionine containing antibiotic. FEBS Microbiol. Lett. 58:263-268.
41. Stein, T., et al. 2002. Dual control of subtilin biosynthesis and immunity in Bacillus subtilis. Mol. Microbiol. 44:403-416.
42. Stein, T., et al. 2002. Two different lantibiotic-like peptides originate from the ericin gene cluster of Bacillus subtilis A1/3. J. Bacteriol. 184:1703-1711.
43. Stein, T. 2008. Whole-cell matrix-assisted laser desorption/ionization mass spectrometry for rapid identification of bacteriocin/lantibiotic-producing bacteria. Rapid Commun. Mass Spectrom. 22:1146-1152.
44. Uchida, K., and E. R. Stadtman. 1992. Selective cleavage of thioether linkage in proteins modified with 4-hydroxynonenal. Proc. Natl. Acad. Sci. U. S. A. 89:5611-5615.
45. Willey, J. M., and W. A. van der Donk. 2007. Lantibiotics: peptides of diverse structure and function. Annu. Rev. Microbiol. 61:477-501.